Results 201 to 210 of about 2,136,365 (369)

Split-APEX implicates splicing factor SRSF1 and splicing helicases in ribosomal biogenesis. [PDF]

Front Mol Biosci
Paschalis V, Wills MFK, De Gusmao Araujo P, Lucas C, Tubasum S, Cui S, Kara H, Bueno-Alejo C, Santana-Vega M, Taladriz-Sender A, Zhao Z, Axer A, Dominguez C, Clark AW, Burley GA, Hudson AJ, Eperon IC.   +16 more
europepmc   +1 more source

Analyzing ordinal data from a split-plot design in the presence of a random block effect

, 2017
Heidi Arnouts, P. Goos
semanticscholar   +1 more source

OPTIONS FOR ANALYZING UNBALANCED SPLIT-PLOT EXPERIMENTS: A CASE STUDY

, 1992
Marta D. Remmenga, Dallas E. Johnson
openalex   +2 more sources

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

PG-SCUnK: measuring pangenome graph representativeness using single-copy and universal K-mers. [PDF]

BMC Bioinformatics
Cumer T, Milia S, Leonard AS, Pausch H.
europepmc   +1 more source

Split-plot designs for multistage experimentation

, 2017
M. Kulahci, J. Tyssedal
semanticscholar   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Differences in drug intake levels (high versus low takers) do not necessarily imply distinct drug user types: Insights from a new cluster-based model. [PDF]

PLoS One
Castaneda DM, Job MO.
europepmc   +1 more source

Response surface in split plot experiment.

, 2000
Telde Natel Custódio, Augusto Ramalho de Morais, Joel Augusto Muniz   +2 more
openalex   +1 more source